Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Provides Conference Call Recording Details

PR Newswire March 27, 2024

MediPharm Labs Reports Fourth Quarter and Full Year Results

PR Newswire March 27, 2024

MediPharm poised to profit from German cannabis legalization

Trevor Abes  March 25, 2024

MediPharm Labs Provides Update on German Cannabis Legalization

PR Newswire March 25, 2024

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results

PR Newswire March 22, 2024

MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority

PR Newswire February 7, 2024

MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program

PR Newswire December 22, 2023

MediPharm Labs Reports Third Quarter Results

PR Newswire November 14, 2023

MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results

PR Newswire November 8, 2023

MediPharm resolves dispute with Tilray, receives $7.27M

Jonathon Brown October 25, 2023

MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash

PR Newswire October 25, 2023

MediPharm Labs Settles an Outstanding Claim for $9M

PR Newswire October 2, 2023

MediPharm Labs boosts Australian presence with new products

Trevor Abes  September 27, 2023

MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market

PR Newswire September 27, 2023

MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement

PR Newswire September 20, 2023

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million

PR Newswire September 5, 2023

Study examines cannabis' impact on anxiety, depression in fibromyalgia patients

Jonathon Brown August 31, 2023

MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients

PR Newswire August 31, 2023

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth

PR Newswire August 14, 2023

MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results

PR Newswire August 10, 2023